Study Shows Trust is still at Heart of NHS COVID App Reluctance

A new study has shown that issues surrounding trust are still at the heart of people's reluctance to download and use the NHS App, particularly among Black, Asian and minority ethnic (BAME) communities.

Researchers from the University of Nottingham's Horizon Digital Research Institute and the Trustworthy Autonomous Systems (TAS) Hub undertook a survey of over 1,000 people and found that while compliance on the part of the approximately 50% of participants who had the app was fairly high, there were issues surrounding trust and understanding that hindered adoption and, therefore, the effectiveness of digital contact tracing, particularly among BAME communities. Their findings have been published in the Journal of Medical Internet Research.

The study involved a nationally representative sample of 16-75 year olds across the UK and took place in December 2020, around 3 months after the app was released.

Results showed that those who chose not to use the app had lower levels of trust, more negative views and less understanding of the app. BAME participants had particularly negative views and were more likely to delete the app. These views include lower trust in the NHS.

Older adults, who are also likely to be more seriously affected by the virus, had more positive views but were also less likely to download the app in the first place. The study also showed that although the intention to follow advice to self-isolate was high, compliance among those who had actually been notified by the app was lower.

Dr Liz Dowthwaite led the study and explains: "This study has revealed a number of issues around trust and compliance, in particular around being notified to self-isolate. Whilst we did not delve into the reasons for this, it may have something to do with the impersonal nature of the app - participants told us they felt it was important that they could verify and get explanations for notifications, as well as that they could speak to a person about what the app told them."

Among the 27.4% of participants who did not intend to download the app, the most common reasons were a desire not to be tracked, not thinking it would be effective, not wanting to take part in contact tracing in that way, and lack of trust in those who built the app. Of the 8.4% who had decided to delete the app, this was mostly because they did not think it was effective or did not want to be tracked.

Liz added: "The findings have implications for the future use of mobile applications for public health; in order to be effective such apps need to be accepted and used by the vast majority of society, and we have seen from this study that there are particular issues in uptake among those most likely to be negatively affected. We believe that It is extremely important to engage the potential users of such technologies at the design stages of these technologies, to identify barriers to use before they are released, in order to enhance uptake."

Dowthwaite L, Fischer J, Perez Vallejos E, Portillo V, Nichele E, Goulden M, McAuley D.
Public Adoption of and Trust in the NHS COVID-19 Contact Tracing App in the United Kingdom: Quantitative Online Survey Study.
J Med Internet Res 2021;23(9):e29085. doi: 10.2196/29085

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...